Sequential Vinorelbine and Docetaxel in Advanced Non-small Cell Lung Cancer Patients Age 70 and Older and/or with a Performance Status of 2: A Phase II Trial of the Southwest Oncology Group (S0027)

This publication has 40 references indexed in Scilit:

• Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)
  Journal of Clinical Oncology, 2005
• Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial
  JNCI Journal of the National Cancer Institute, 2003
• Cisplatin-Based Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Implications of Eastern Cooperative Oncology Group 5592, a Randomized Trial
  JNCI Journal of the National Cancer Institute, 2002
• Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2000
• Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
  New England Journal of Medicine, 1999
• Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1999
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Chemotherapy vs Supportive Care in Advanced Non-Small-Cell Lung Cancer
  Chest, 1994
• Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?
  Journal of Clinical Oncology, 1993
• Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
  The Lancet, 1993